Find More Contacts for Neurotech
Protected Content
CEO
Executive Management
1 email found
View contacts for Neurotech to access new leads and connect with decision-makers.
View All Contacts
  • Company Type For Profit
  • Contact Email contact@neurotechusa.com
  • Phone Number 401-333-3880
Neurotech is a privately held biotechnology company developing sight-saving therapeutics for chronic retinal diseases—including indications with significant unmet medical need that, as a whole, represent the largest market opportunity in ophthalmology.

Lists Featuring This Company

Hospital Startups
842 Number of Organizations • $12.3B Total Funding Amount • 2,688 Number of Investors
Hospital Companies With Less Than $1B in Revenue (Top 10K)
9,675 Number of Organizations • $52.2B Total Funding Amount • 4,187 Number of Investors
Medical Companies With More Than 10 Employees (Top 10K)
9,915 Number of Organizations • $573.8B Total Funding Amount • 28,240 Number of Investors
East Coast Early Stage Companies With Less Than $50M in Revenue
2,822 Number of Organizations • $92B Total Funding Amount • 19,145 Number of Investors

Frequently Asked Questions

Where is Neurotech's headquarters? Neurotech is located in Lincoln, Rhode Island, United States.Who invested in Neurotech? Neurotech has 14 investors including Burrill & Company and Triginta Capital.How much funding has Neurotech raised to date? Neurotech has raised .When was the last funding round for Neurotech? Neurotech closed its last funding round on Nov 16, 2006 from a Series B round.Who are Neurotech's competitors? Alternatives and possible competitors to Neurotech may include Rakuten MedicalInterius BioTherapeutics, and Eureka Therapeutics.